£106.80

It has never been this cheap. We have no record of a lower price.

£107 today · cheaper than every other day in the last 3 months

Lippincott Williams & Wilkins The International Consensus Classification of Myeloid and Lymphoid Neoplasms

View at Amazon

Price History & Forecast

Grey patches = out of stock. Cheaper = lower on the chart. Hover for exact prices.

Last 49 days · 49 data points (no recent data)

Historical
Generating forecast…
£106.80 £101.46 £103.60 £105.73 £107.87 £110.00 £112.14 25 July 2026 06 August 2026 18 August 2026 30 August 2026 11 September 2026
View at Amazon ↗

Price data last checked 42 day(s) ago - refreshing...

NEW HERE?

Amazon shows you one price. We show you all of them.

Tosheroon watches Amazon prices so you don't have to. Every product on Amazon has a price history — we make it visible. Set the price you'd actually pay, and we'll email you the second it gets there. No app, no account, one email.

WHAT'S ON THIS PAGE

↑ Price chart
when this has been cheap or pricey
↑ Forecast
where the price is heading next
↓ Statistics
all-time high & low, recent range
↑ Price alert
name your number, we'll email you

Price Distribution

Price distribution over 49 days • 1 price levels

Days at Price
49 days 0 12 25 37 49 £107 Days at Price

Price Analysis

Most common price: £107 (49 days, 100.0%)

Price range: £107 - £107

Price levels: 1 different prices over 49 days

Description

Developed by 149 experts in the field, The International Consensus Classification of Myeloid and Lymphoid Neoplasms provides key information for use at the microscope to assist in arriving at a swift and accurate diagnosis. Drs. Daniel Arber, Michael J. Borowitz, James Cook, Laurence de Leval, John Goodlad, Robert Hasserjian, Rebecca L. King, Hans-Michael Kvasnicka, and Attilio Orazi lead a team of authors who focus on diagnostic criteria and the clinical significance of each disease entity. • Offers up-to-date information developed through a Clinical Advisory Committee (CAC) process that included the authors and editors of the former 3rd, 4th, and revised 4th edition World Health Organization (WHO) classification of hematopoietic and lymphoid tumors • Focuses on diagnostic criteria and includes guidelines as to the clinical significance of each disease authored by a clinician expert • Provides essential information for pathologists and hematopathologists in practice and in training, as well as oncologists and hematologists who want to better understand the many disease categories that they encounter ,

Key Features

New Store Stock

Product Specifications

Format
hardcover
Domain
Amazon UK
Release Date
03 January 2025
Listed Since
18 June 2024

Barcode

No barcode data available

Similar Products You Might Like

Neoplastic Hematopathology, An Issue of Hematology/Oncology Clinics of North America (Volume 23-4) (The Clinics: Internal Medicine, Volume 23-4)
97% match

Neoplastic Hematopathology, An Issue of Hematology/Oncology Clinics of North America (Volume 23-4) (The Clinics: Internal Medicine, Volume 23-4)

Elsevier

£50.03 23 Sep 2026
Neoplastic Hematopathology: Experimental and Clinical Approaches (Contemporary Hematology)
97% match

Neoplastic Hematopathology: Experimental and Clinical Approaches (Contemporary Hematology)

Humana

£170.00 27 Aug 2026
Neoplastic Hematopathology: Experimental and Clinical Approaches (Contemporary Hematology)
97% match

Neoplastic Hematopathology: Experimental and Clinical Approaches (Contemporary Hematology)

Humana

£194.27 25 Sep 2026
Diagnostic Pathology of Hematopoietic Disorders of Spleen and Liver
97% match

Diagnostic Pathology of Hematopoietic Disorders of Spleen and Liver

Springer

£73.57 18 Sep 2026
WHO Haematolymphoid Tumours Volume 11 5th Edition - Blue Books
97% match

WHO Haematolymphoid Tumours Volume 11 5th Edition - Blue Books

World Health Organization

£186.45 19 Sep 2026
Consulting Hematology and Oncology Handbook
97% match

Consulting Hematology and Oncology Handbook

Springer

£59.97 23 Sep 2026
Bone Marrow: A Practical Manual (Vademecum)
97% match

Bone Marrow: A Practical Manual (Vademecum)

CRC Press

£55.99 03 Oct 2026
Atlas of Clinical Hematology
97% match

Atlas of Clinical Hematology

Springer

£92.43 23 Aug 2026
Understanding Leukemias, Lymphomas and Myelomas
97% match

Understanding Leukemias, Lymphomas and Myelomas

CRC Press

£62.60 23 Sep 2026
Ioachim's Lymph Node Pathology
97% match

Ioachim's Lymph Node Pathology

Lippincott Williams & Wilkins

£201.10 26 Sep 2026
Atlas of Differential Diagnosis in Neoplastic Hematopathology
97% match

Atlas of Differential Diagnosis in Neoplastic Hematopathology

CRC Press

£197.77 24 Aug 2026
Hematopathology of the Skin: Clinical & Pathological Approach
97% match

Hematopathology of the Skin: Clinical & Pathological Approach

Lippincott Williams & Wilkins

£218.36 25 Aug 2026
Diagnostic Pathology: Lymph Nodes and Extranodal Lymphomas
97% match

Diagnostic Pathology: Lymph Nodes and Extranodal Lymphomas

Elsevier

£193.67 26 Aug 2026
Understanding Leukemias, Lymphomas and Myelomas
97% match

Understanding Leukemias, Lymphomas and Myelomas

CRC Press

£80.99 23 Sep 2026
Lymphoma: Methods and Protocols - Volume 971 Research Guide
97% match

Lymphoma: Methods and Protocols - Volume 971 Research Guide

Humana

£101.40 02 Oct 2026
Pädiatrische Hämatologie und Onkologie (Springer Reference Medizin)
96% match

Pädiatrische Hämatologie und Onkologie (Springer Reference Medizin)

Springer

£141.67 24 Aug 2026
Cancer Consult: Expertise in Clinical Practice, Volume 2: Neoplastic Hematology & Cellular Therapy
96% match

Cancer Consult: Expertise in Clinical Practice, Volume 2: Neoplastic Hematology & Cellular Therapy

Wiley

£96.26 11 Sep 2026
Hematologic Cancers: Molecular Pathobiology to Targeted Therapeutics
96% match

Hematologic Cancers: Molecular Pathobiology to Targeted Therapeutics

Springer

£113.76 03 Oct 2026
Pocket Guide to Diagnostic Hematopathology
96% match

Pocket Guide to Diagnostic Hematopathology

Springer

£60.11 24 Sep 2026
Resistance to Targeted Therapies in Lymphomas: 21 (Resistance to Targeted Anti-Cancer Therapeutics, 21)
96% match

Resistance to Targeted Therapies in Lymphomas: 21 (Resistance to Targeted Anti-Cancer Therapeutics, 21)

Springer

£71.02 18 Sep 2026